Company news
CANbridge Pharmaceuticals Inc. news in 2026
CANbridge Pharmaceuticals Inc.'s news releases, calls and decks from 2026, newest first.
Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
November 5, 2026
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
October 6, 2026
Interim report 2026
September 25, 2026
CANbridge Announces NHIA Reimbursement Approval of Livmarli for Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis in Taiwan
August 18, 2026